Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Research and development

Litigation settlement gain

Restructuring and other charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Align Technology

Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Align Technology reports Q4 growth, eyes tech advancements for 2023

Align Technology's Q4 performance showed revenue growth in Systems and Services but challenges in Clear Aligner volumes, particularly in China.
The company is focusing on technology advancements, digital subscriptions, and margin improvement for 2023.
Investments in R&D for digital orthodontics and subscription programs present opportunities for future growth.
Despite challenges in China, Align remains optimistic about stability and growth in other regions.

Align Technology beats Q1 revenue expectations, eyes Q2 growth

Align Technology's Q1 performance exceeded expectations with revenue growth.
Stable Clear Aligner business and focus on teen market are strengths.
Challenges include increased expenses and uncertainty in margins.
Opportunities lie in expected volume and ASP increases in Q2.

Align Technology surpasses Q2 expectations, eyes international growth opportunities

Align Technology delivered strong Q2 results, driven by revenue growth in Clear Aligner and Systems and Services segments, with a focus on innovation and strategic initiatives.
The company's performance in international markets, particularly EMEA and APAC, showcased significant growth in teen cases and adoption of the DSP program.
While facing challenges in the teen market and competitive landscape, Align Technology remains optimistic about its long-term growth prospects and market positioning.
Opportunities for Align include continued innovation, market expansion, and investor engagement through strategic initiatives and product differentiation.

Align Technology reports Q3 revenue growth amidst macro challenges

Align Technology navigated challenges in Q3 with revenue growth driven by clear aligner shipments to younger patients and increased services revenue.
Despite lower Q3 demand, the company remains optimistic for 2024 revenue growth through new technologies and digital orthodontics adoption.
Strategic investments in R&D, cost management, and consumer advertising position Align Technology for future growth and margin improvement.

Align Technology surpasses Q4 expectations, eyes innovation for growth

Align Technology delivered strong financial performance in Q4 2023, with robust revenue growth and effective cost management.
The company's focus on innovation, strategic partnerships, and market expansion positions it well for future growth.
While facing challenges such as regulatory approvals and cash flow fluctuations, Align Technology has opportunities in market expansion and cost-saving initiatives.
Overall, Align Technology's performance, strengths, and strategic outlook indicate a positive trajectory for sustainable growth and profitability.

Align Technology posts solid Q1 earnings, eyes growth opportunities

Align Technology's Q1 performance reflects revenue growth and strategic investments in innovation and market expansion.
While facing challenges in operating expenses and margin decline, the company's strengths lie in product innovation and brand visibility.
Opportunities in new market expansion, targeting younger patients, and operational investments set the stage for future growth and profitability.

Align Technology posts solid Q2 results, eyes market expansion

Align Technology delivered strong financial performance in Q2, driven by revenue growth, margin expansion, and increasing adoption of its innovative solutions.
The company's focus on product innovation, digital tools, and marketing initiatives has bolstered its market position and customer engagement.
While facing challenges in a competitive landscape and regulatory processes, Align Technology remains well-positioned to capitalize on opportunities in the orthodontic market.
Strategic initiatives to drive growth, enhance operational efficiency, and expand market reach are key priorities for sustaining momentum and profitability.

Align Technology reports mixed Q3 results, eyes international growth

Align Technology's Q3 '24 showcased mixed results but highlighted growth opportunities in international markets and new product innovations.
Despite challenges in the U.S. market, the company's strategic focus on operational efficiency and digital innovation positions it for future success.
Investments in expansion and supporting doctor customers signal a commitment to driving growth and profitability in the long term.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Here is how Align Technology (ALGN) and atai Life Sciences N.V. (ATAI) have performed compared to their sector so far this year.

Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?

SYDNEY--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align's Invisalign Palatal Expander System* has been included in the Australian Register of Therapeutic Goods (ARTG) and the New Zealand Web Assisted Notification of Devices Dat.

Invisalign® Palatal Expander System by Align Technology Now Available in Australia and New Zealand for Skeletal and Dental Expansion in Growing Patients

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2024 financial results on Wednesday, April 24, 2024, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and wi.

Align Technology to Announce First Quarter 2024 Results on April 24, 2024

In terms of innovation, Align Technology successfully launched its first subscription-based clear aligner program Doctor Subscription Program (DSP) worldwide.

Align Technology (ALGN) Gains From Innovation, Macro Issues Ail

Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?

Align Technology (ALGN) Up 10.6% Since Last Earnings Report: Can It Continue?

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that on Wednesday, February 21, 2024, the U.S. District Court for the Northern District of California granted summary judgment in favor of Align Technology, Inc. in two U.S. antitrust c.

U.S. District Court for Northern District of California Grants Summary Judgment in Favor of Align Technology in Two Antitrust Class Action Lawsuits

Investors are optimistic about Align Technology (ALGN) on continued geographic expansion.

Here's Why You Should Retain Align Technology (ALGN) Stock Now

Merit Medical Systems

Investors interested in Medical - Dental Supplies stocks are likely familiar with Merit Medical (MMSI) and Align Technology (ALGN). But which of these two stocks presents investors with the better value opportunity right now?

MMSI vs. ALGN: Which Stock Is the Better Value Option?

Align Technology outperformed expectations in its most recent quarter and expects ongoing growth in the coming year. The stock is up about 50% in three months, which may be motivation for some to sell.

Why Align Technology Stock Soared in Early Trading on Thursday

Align Technology (ALGN) surpasses revenue and earnings estimates in the fourth quarter of fiscal 2023.

Align Technology (ALGN) Q4 Revenues Top, Margins Expand

Align Technology, Inc. (ALGN) Q4 2023 Earnings Call Transcript

Although the revenue and EPS for Align Technology (ALGN) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Align Technology (ALGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Align Technology forecast first-quarter revenue above Wall Street estimates on Wednesday, aided by increased demand for its clear teeth aligners, sending its shares up 10% in extended trading.

Align Technology shares jump after upbeat first-quarter revenue forecast

Invisalign-maker Align Tech crushed fourth-quarter expectations late Wednesday, leading ALGN stock to retake its 200-day line.

Invisalign-Maker Align Crushes Quarterly Forecasts And Makes A Bullish Move

Shares of Align Technology Inc. ALGN, +0.97% jumped 14.1% after hours on Wednesday after the company, best known for its Invisalign teeth-alignment system, forecast first-quarter and full-year sales that were above expectations. Align said it expected first-quarter sales of $960 million to $980 million, above the FactSet consensus forecast for $947 million.

Shares of Invisalign maker Align Technology rally on forecast

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that for the first time, Align Technology is included in the Intellectual Property Owners Association annual report of the top 300 organizations granted U.S. patents. For 2023, Align is.

Align Technology Among Top 300 Worldwide Organizations Granted U.S. Patents in 2023

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the fourth quarter ("Q4'23") and year ended December 31, 2023 ("2023"). Q4'23 total revenues were $956.7 million, down 0.4% sequentially and up 6.1% year-over-year.

Align Technology Announces Fourth Quarter and Fiscal 2023 Financial Results

SAN JOSE, Calif. & TEMPE, Ariz. & PETACH TIKVA, Israel--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the launch of the iTero Lumina™ intraoral scanner – with a 3X wider field of capture in a 50% smaller and 45% lighter wand, delivering faster sc.

Align Technology Announces New iTero Lumina™ Intraoral Scanner Featuring a 3X Wider Field of Capture1 in a 50% Smaller Wand2 That Delivers Faster Scanning, Higher Accuracy3, and Superior Visualization4 for Greater Practice Efficiency

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Align Technology (ALGN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.

Gear Up for Align Technology (ALGN) Q4 Earnings: Wall Street Estimates for Key Metrics

Foreign exchange continues to be a major headwind for Align (ALGN) due to a considerable percentage of its revenues coming from outside the United States.

Align (ALGN) Ailed by Macroeconomic Issues & Currency Headwind

Align Technology's (ALGN) fourth-quarter 2023 results are likely to reflect the strength of the Clear Aligner and Systems & Services businesses.

Align Technology (ALGN) to Post Q4 Earnings: What's in Store?

SAN JOSE, Calif. & TEMPE, Ariz. & VIENNA--(BUSINESS WIRE)--Align Technology, Inc. (Align) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has completed the acquisition of privately-held Cubicure GmbH, a pioneer in direct 3D printing solutions for polymer additive manufacturing th.

Align Technology Completes Acquisition of Cubicure, a Pioneer of Direct 3D Printing Solutions for Polymer Additive Manufacturing

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report fourth quarter and 2023 financial results on Wednesday, January 31, 2024, after the close of market. Financial results will be released at 4:00 p.m. ET (2:00 p.m. MT.

Align Technology to Announce Fourth Quarter and 2023 Results on January 31, 2024

Investors are optimistic about Align Technology (ALGN), driven by recent strategic alliance and geographic expansion.

Align Technology (ALGN) Up 30% YTD: Will the Rally Continue?

Because the past few months in the stock market have been a wild emotional roller coaster, most investors are now looking for the most logical and fundamental reasons to justify investing in any sector. Today, new pieces of data are being blasted across your monitor, so it is alright to feel pulled in a thousand directions.

News for Align Technology Stock (ALGN)